MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Biocompatible and biodegradable nanoparticles

University of Liège (ULg), Interface Entreprises-Université, Liege
Biocompatible and biodegradable nanoparticles designed to encapsulate drug allowing for its absorption and delivery

Mechanism of action

-

Full description

The invention allows production of biocompatible and biodegradable pseudolatex particles with a homogeneous size below 140nm. The nanoparticles of the invention advantageously show efficient immobilization of proteinaceous drugs (peptide, proteins, or other sensitive biopharmaceutical drugs) by preserving their activity and allowing for their controlled release. The nanoparticles are stable colloidal carriers against environmental attacks such as pH modifications or freezing or freezedrying processes. Drugs and drug combinations are adhered on/or incorporated in nanoparticles which can then be applied in methods of treating patients. Administration can be oral, intraperitoneal, topical, intranasal or intravenous. The drug which can be used according to the invention is a low molecular lipophilic compound or polypeptide: diazepam, antibiotics, anesthetics, antimitotics, enzymes, antigen molecules (BSA), somatotropin, tetanus toxoid, influenza virus, to name a few. Examples of treatments are clinical applications such as diabetes and tumour treatment, inflammation and intracellular infection treatment, adjuvant for vaccine, vaccine controlled delivery (HIV virus or influenza)

Patent information

PATENT STATUS: Granted : EP, US, JP, CA

Type of business relationship sought

International license opportunities are available

Licensing contact

Dr Nicole Antheunis

Contact directly

Company details

University of Liège (ULg), Interface Entreprises-Université, Liege

The Interface Entreprises-Université is a multidisciplinary team committed to industry, which is responsible of the Liège University technology transfer (IP protection, licences, spinoff

View profile

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us